Viewing Study NCT05554003

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:09 PM
Ignite Modification Date: 2026-01-25 @ 3:22 AM
Study NCT ID: NCT05554003
Status: RECRUITING
Last Update Posted: 2024-11-18
First Post: 2022-09-21
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study
Sponsor: European Institute of Oncology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
None Frailty View
None Chemotherapy Effect View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Temozolomide View
None Neuroendocrine tumors View
None NETs View
None NENs View
None Unfit View
None Chemotherapy View
None Metronomic View
None Advanced View
None Phase II View
None Open label View